Filing Details
- Accession Number:
- 0001144204-14-024307
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-04-23 16:45:32
- Reporting Period:
- 2014-04-22
- Filing Date:
- 2014-04-23
- Accepted Time:
- 2014-04-23 16:45:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1510614 | Kevin Horgan | C/O Coronado Biosciences, Inc. 24 New England Executive Park Burlington MA US 01803 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-04-22 | 47,566 | $1.71 | 47,566 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-04-22 | 47,566 | $1.89 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase Common Stock | Disposition | 2014-04-22 | 47,566 | $0.00 | 47,566 | $1.71 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2023-11-05 | No | 4 | M | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $1.81 to $1.95. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the trades were effected.
- The vesting of one-third of the shares subject to this option was accelerated upon Dr. Horgan's separation of service from the Issuer.